Medicare (CMS) Local Coverage Determination (LCD) Updates – March 2019

Centers for Medicare & Medicaid Services (CMS) Local Coverage Determination (LCD) Updates »

March 2019 Medicare (CMS) LCD Updates:

• L33417               Allergy Skin Testing
• A56368               Billing and Coding: Varicose Veins and Lower Extremities
• A56368               Billing and Coding: Varicose Veins and Lower Extremities
• L34573               Cardiac Event Detection
• L37193 (retired)  Coenzyme Q10 Testing
• L34037               Flow Cytometry
• A52385               Flow Cytometry – Supplemental Instructions Article
• L33970 (retired)  Frequency of Hemodialysis Services
• A55565               Gemcitabine (Gemzar®) revision to the Part A and Part B LCD
• A53826 (retired)  HemoDialysis Frequency
• A53828 (retired)  HemoDialysis Frequency
• L37066               Lab: Coenzyme Q10 (CoQ10)
• L37068               Lab: Coenzyme Q10 (CoQ10)
• L36358               MolDX: Biomarkers in Cardiovascular Risk Assessment
• L36362               MolDX: Biomarkers in Cardiovascular Risk Assessment
• A56371               MolDX: Oncotype DX® Genomic Prostate Score Coding and Billing Article
• A56372               MolDX: Oncotype DX® Genomic Prostate Score Coding and Billing Article
• L36524               Nerve Conduction Studies and Electromyography
• L36526               Nerve Conduction Studies and Electromyography
• A52406               Panretinal (Scatter) Laser Photocoagulation – Supplemental Instructions Article
• L34064               Panretinal (Scatter) Laser Photocoagulation
• A52516               Patient Lifts – Policy Article
• L34085               Post-Void Residual Urine and/or Bladder Capacity by Ultrasound
• L34539               Psychological Services Coverage under the Incident to Provision for Physicians and Non-physicians
• A52517               Respiratory Assist Devices – Policy Article
• A56105 (retired)  Response to Comments: MolDX: ProMark Risk Score
• A56369               Response to Comments: Varicose Veins of the Lower Extremities
• A52518               Seat Lift Mechanisms – Policy Article
• A52713               Transcutaneous Electrical Joint Stimulation Devices (TEJSD) – Policy Article
• A52712               Vacuum Erection Devices (VED) – Policy Article
• L33454               Varicose Veins of the Lower Extremities
• A52503               Walkers – Policy Article
• L36690               Wound Application of Cellular and/or Tissue Based Products (CTPs), Lower Extremities
• L33416            3D Interpretation and Reporting of Imaging Studies
• A56384           Billing and Coding for Supervised Exercise Therapy for the Treatment of Peripheral Arterial Disease with Symptomatic Lower Extremity Intermittent Claudication
• A56384           Billing and Coding for Supervised Exercise Therapy for the Treatment of Peripheral Arterial Disease with Symptomatic Lower Extremity Intermittent Claudication
• A56380           Billing and Coding: Rituximab (Rituxan®)
• A56380           Billing and Coding: Rituximab (Rituxan®)
• L34411            Blepharoplasty, Eyelid Surgery, and Brow Lift
• L34454            Colonoscopy/Sigmoidoscopy/Proctosigmoidoscopy
• L37641            Continuous Peripheral Nerve Blocks (CPNB)
• L36351            Lab: Special Histochemical Stains and Immunohistochemical Stains
• L36353            Lab: Special Histochemical Stains and Immunohistochemical Stains
• A55802           Lab: Special Stains and Immunohistochemistry (IHC) Indications for Gastric Pathology
• A55803           Lab: Special Stains and Immunohistochemistry (IHC) Indications for Gastric Pathology
• A55711           MolDX: Abbott RealTime IDH1 and IDH2 testing for Acute Myeloid Leukemia (AML) Billing and Coding Guidelines
• A55712           MolDX: Abbott RealTime IDH1 and IDH2 testing for Acute Myeloid Leukemia (AML) Billing and Coding Guidelines
• L37834            MolDX: Decipher® Biopsy Prostate Cancer Classifier Assay for Men with Very Low and Low Risk Disease
• L37070            MolDX: DecisionDx-UM (Uveal Melanoma)
• L37072            MolDX: DecisionDx-UM (Uveal Melanoma)
• L37859            MolDX: myPath Melanoma Assay
• A56379           Response to Comments: MolDX: myPath Melanoma Assay
• A56114 (retired)        Response to Comments: MolDX: Prolaris™ Prostate Cancer Genomic Assay
• L35026            Rituximab (Rituxan®)
• L35026            Rituximab (Rituxan®)
• L37774            Supervised Exercise Therapy for the Treatment of Peripheral Arterial Disease with Symptomatic Lower Extremity Intermittent Claudication

Centers for Medicare & Medicaid Services (CMS) Local Coverage Determination (LCD) Updates »

Policy Alerts monitors Commercial and Medicare medical policies for changes. While medical Insurance carriers typically update medical policies annually, there are many reasons why they might review or update a policy. When reviews occur out of cycle they often go unnoticed. Policy Alerts keeps you updated when Payers make coverage changes to medical policies affecting your business.

Policy Alerts continuously monitors Commercial and Medicare Payer coverage information to keep you up-to-date on medical Insurance decisions in real-time. When changes occur, instant email alerts are delivered to your inbox. Clients have access to detailed coverage reports and medical policies through the interactive Policy Alerts Dashboard portal. Save time each month and keep focused on important Payer medical policy reviews and coverage decisions affecting your business!

Policy Alerts takes a client-focused hands-on approach and is constantly working to provide our customers with helpful insights and actionable analytics. We understand what our clients need and are dedicated to providing timely, accurate, and always up-to-date reports.

Health economic and reimbursement information provided by Policy Alerts is gathered from third-party sources and is subject to change without notice as a result of complex and frequently changing laws, regulations, rules and policies. All product and company names are trademarks™ or registered® trademarks of their respective holders. Use of them does not imply any affiliation with or endorsement by them. This information is presented for illustrative purposes only and does not constitute reimbursement or legal advice.